Nectar Lifescience Ltd Quarterly Results

Gross Sales

504.12

497.45

417.51

511.68

513.52

Excise Duty

49.79

69.56

58.66

71.84

61.35

Net Sales

454.33

427.88

358.85

439.85

452.16

Other Operating Income

0.65

0.21

0.45

1.53

0.01

Other Income

0.57

0.69

0.55

1.47

0.48

Total Income

455.56

428.79

359.85

442.84

452.65

Total Expenditure

410.27

384.76

319.5

392.87

409.98

PBIDT

45.28

44.02

40.35

49.97

42.67

Interest

17.12

19.81

19.98

24.16

24.84

PBDT

28.16

24.21

20.38

25.81

17.83

Depreciation

15.61

15.55

15.46

14.7

15.37

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

4.71

3.07

1.95

10.52

0.89

Reported Profit After Tax

7.84

5.6

2.97

0.59

1.57

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

7.84

5.6

2.97

0.59

1.57

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

7.84

5.6

2.97

0.59

1.57

EPS (Unit Curr.)

0.35

0.25

0.13

0.03

0.07

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.96

10.28

11.24

11.36

9.43

PBDTM(%)

6.19

5.65

5.67

5.86

3.94

PATM(%)

1.72

1.3

0.82

0.13

0.34